Targeting TAp63 in Breast Cancer.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 368
- Publication type:
- Article
Works matching IS 08909091 AND DT 2021 AND VI 35 AND IP 6
Results: 16
1
2
HER2-Positive Breast Cancer: Special Challenges and Expert Insight.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 363
- By:
- Publication type:
- Article
3
Management of Genitourinary Malignancies.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 356
- Publication type:
- Article
4
Advances in Later-Line Management of Relapsed/Refractory Follicular Lymphoma.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 354
- By:
- Publication type:
- Article
5
Individualizing Extended Adjuvant Therapy in HR+ Breast Cancer.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 350
- By:
- Publication type:
- Article
6
EXPERT COMMENTARY ON THE PRODUCT PROFILE OF Tazemetostat for Follicular Lymphoma.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 346
- Publication type:
- Article
7
Mucinous Adenocarcinoma of the Appendix With Histologic Response to Neoadjuvant Chemotherapy: Review of Histologic and Clinical Spectrum of Epithelial Neoplastic Mucinous Lesions of the Appendix.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 335, doi. 10.46883/onc.2021.3506.0335
- By:
- Publication type:
- Article
8
Emergency Fertility Preservation in a Young Woman With Non-Hodgkin Lymphoma.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 332, doi. 10.46883/onc.2021.3506.0332
- By:
- Publication type:
- Article
9
Routine Breast Cancer Screening in Average-Risk Women Younger Than 50 Years: Current Paradigms Based on National Guidelines.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 320, doi. 10.46883/onc.2021.3506.0320
- By:
- Publication type:
- Article
10
Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer: Past, Present, and Future.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 311, doi. 10.46883/onc.2021.3506.0311
- By:
- Publication type:
- Article
11
Handling Prior Authorizations Electronically May Offer Solutions for Slow Systems.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 310
- By:
- Publication type:
- Article
12
Navigating an Optimal Treatment Course for Advanced Kidney Cancer.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 308, doi. 10.46883/onc.2021.3506.0308
- By:
- Publication type:
- Article
13
Second-Line Therapies in the Changing Landscape of First-Line Therapies for Metastatic Clear Cell Renal Cell Cancer.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 306, doi. 10.46883/onc.2021.3506.0306
- By:
- Publication type:
- Article
14
Friendly Competition Fosters Progress in Hematologic Malignancies.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 304
- Publication type:
- Article
15
The Future of Oncology: Supply and Demand for Oncology Services.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 303
- By:
- Publication type:
- Article
16
Improving Outcomes After Frontline Therapy.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 298
- By:
- Publication type:
- Article